Notice: This company has been marked as potentially delisted and may not be actively trading. Zosano Pharma (ZSAN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Aktuelle Empfehlungen zur ZOSANOJuly 28, 2024 | finanznachrichten.deHOOK HOOKIPA Pharma Inc.April 12, 2024 | seekingalpha.comEast Bay Business NewsMay 18, 2023 | bizjournals.comAstellas PharmaApril 6, 2023 | forbes.comGiiant Pharma Receives Financial Support From the US Crohn’s and Colitis FoundationFebruary 5, 2023 | finance.yahoo.comZosano Pharma Corporation (ZSANQ)November 5, 2022 | ca.finance.yahoo.comBankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma GiantsOctober 12, 2022 | msn.comBankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of ClaimsAugust 28, 2022 | marketwatch.comEast Bay migraine patch developer Zosano closes sale in bankruptcy court for $1 millionAugust 27, 2022 | bizjournals.comZosano Pharma Corp (ZSANQ)August 25, 2022 | investing.comEast Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1MJuly 26, 2022 | bizjournals.comA Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.July 26, 2022 | bizjournals.comZosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSANJune 2, 2022 | marketwatch.comWhy Zosano Pharma Shares Are Getting Hammered TodayJune 2, 2022 | msn.comZosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%June 2, 2022 | seekingalpha.comCash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSANJune 2, 2022 | marketwatch.comEast Bay migraine patch developer files for bankruptcyJune 2, 2022 | bizjournals.comZosano Pharma Files Voluntary Petition for Relief Under Chapter 11June 2, 2022 | finance.yahoo.comTrading was temporarily halted for "ZSAN" at 07:06 AM with a stated reason of "News pending."June 2, 2022 | marketbeat.comEmergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle PatchMay 18, 2022 | apnews.comZosano Pharma Reports Q1 Net Loss of $33.4MMay 13, 2022 | investing.comZosano Pharma Reports First Quarter 2022 Financial ResultsMay 13, 2022 | finance.yahoo.comZosano Pharma Corporation (ZSAN) Outpaces Stock Market Gains: What You Should KnowMay 3, 2022 | finance.yahoo.comMigraine patch Zosano Pharma developer suspends program, cutting more jobsApril 29, 2022 | bizjournals.comMigraine patch developer Zosano Pharma suspends program, cutting more jobsApril 29, 2022 | finance.yahoo.comZosano Pharma suspends program for migraine treatment M207April 29, 2022 | seekingalpha.comZosano Pharma Provides Corporate UpdateApril 29, 2022 | finance.yahoo.comZosano Pharma slips as reverse stock split takes effectApril 12, 2022 | seekingalpha.comZosano Pharma Announces Reverse Stock Split Effective TodayApril 11, 2022 | finance.yahoo.comZosano Pharma (NASDAQ:ZSAN) Receives New Coverage from Analysts at StockNews.comStockNews.com initiated coverage on shares of Zosano Pharma in a report on Saturday. They set a "sell" rating for the company.March 26, 2022 | marketbeat.comLooking Into Zosano Pharma's Return On Capital EmployedMarch 18, 2022 | benzinga.comZosano Pharma (NASDAQ:ZSAN) Coverage Initiated at StockNews.comStockNews.com initiated coverage on Zosano Pharma in a report on Friday. They issued a "sell" rating for the company.March 18, 2022 | marketbeat.comZosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsMarch 17, 2022 | finance.yahoo.comZosano Pharma (NASDAQ:ZSAN) Downgraded by BTIG ResearchBTIG Research cut Zosano Pharma from a "buy" rating to a "neutral" rating in a research note on Wednesday.February 23, 2022 | marketbeat.comZosano Pharma plunges 48% on pricing $15.4M common stock and warrants offeringFebruary 9, 2022 | seekingalpha.comZosano Pharma Announces Publication Of Early Data On Influenza VaccineJanuary 5, 2022 | finance.yahoo.comZosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseJanuary 5, 2022 | finance.yahoo.comAiming to make Covid vaccines easier to take, East Bay company pushes forward with microneedle patchNovember 17, 2021 | finance.yahoo.comZosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch SystemNovember 17, 2021 | finance.yahoo.comZosano Pharma Reports Third Quarter 2021 Financial ResultsNovember 10, 2021 | finance.yahoo.comThinking about buying stock in Zosano Pharma, SoFi Technologies, Quantumscape, Nokia, or Hexo?November 1, 2021 | benzinga.comCSols Inc. Validates New LIMS at Zosano PharmaOctober 26, 2021 | businesswire.comZosano Pharma 8-K Shows Co. Refined Strategy For Resubmission Of M207 Microneedle System New Drug Application To FDAOctober 8, 2021 | benzinga.comZosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study ResultsOctober 4, 2021 | finance.yahoo.comZosano Pharma granted patent related to migraine treatment M207July 23, 2021 | seekingalpha.com Get Zosano Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZSAN and its competitors with MarketBeat's FREE daily newsletter. Email Address ZSAN Media Mentions By Week ZSAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZSAN News Sentiment▼0.000.75▲Average Medical News Sentiment ZSAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZSAN Articles This Week▼00▲ZSAN Articles Average Week Get Zosano Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZSAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MTEM News Today AMPE News Today CLVR News Today EFTR News Today PROC News Today SEEL News Today LLY News Today NVO News Today JNJ News Today ABBV News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZSAN) was last updated on 1/29/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zosano Pharma Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zosano Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZSAN Stock Alerts